Recent Posts

• Immunotherapy Available for Tumors Identified as dMMR or MSI-H
• Updated ASCO Guidelines for Stage IV NSCLC Use PD-L1 Testing to Assist in Selection of Therapy
• CSI Laboratories Partnership with Avalon Healthcare Solutions to Benefit Patients in South Carolina
• Join Us @ Booth #640 in San Antonio for USCAP 2017